FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Clara Montagut

Research Profile

Chemicals & Drugs

Physiology

Drug Resistance, Neoplasm

Disorders

Procedures

Co-author Network

Publications

TOP 3
M Pera; L Pétriz; A Reig; Dulce Momblan; Clara Montagut; C Balagué; Joaquim Bellmunt; C Conill; R Gallego; M Iglesias; M Martín-Richard; J Maurel
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer.
Clara Montagut; Silvia Pairet; Ana Rovira; Marta Salido; Sergi Serrano; Jeff Settleman; Seshagiri Somasekar; Siao Ping Tsai; Somasekar Seshagiri; Joaquim Bellmunt; Beatriz Bellosillo; Francesc Bosch; Marta Crespo; Alba Dalmases; Manuel Gallen; Heinz Himmelbauer; Mar Iglesias; Scot Marsters; André Minoche; Joan Albanell
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.
Clara Montagut; M Iglesias; M Arumi; B Bellosillo; M Gallen; A Martinez-Fernandez; L Martinez-Aviles; I Cañadas; Alba Dalmases; E Moragon; L Lema; Sergi Serrano; Ana Rovira; Federico Rojo; Joaquim Bellmunt; Joan Albanell
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Clara Montagut (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: M Pera; L Pétriz; A Reig; Dulce Momblan; Clara Montagut; C Balagué; Joaquim Bellmunt; C Conill; R Gallego; M Iglesias; M Martín-Richard; J Maurel
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):664-70.
2012: Clara Montagut; Silvia Pairet; Ana Rovira; Marta Salido; Sergi Serrano; Jeff Settleman; Seshagiri Somasekar; Siao Ping Tsai; Somasekar Seshagiri; Joaquim Bellmunt; Beatriz Bellosillo; Francesc Bosch; Marta Crespo; Alba Dalmases; Manuel Gallen; Heinz Himmelbauer; Mar Iglesias; Scot Marsters; André Minoche; Joan Albanell
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.
Nature medicine 2012;18(2):221-3.
2010: Clara Montagut; M Iglesias; M Arumi; B Bellosillo; M Gallen; A Martinez-Fernandez; L Martinez-Aviles; I Cañadas; Alba Dalmases; E Moragon; L Lema; Sergi Serrano; Ana Rovira; Federico Rojo; Joaquim Bellmunt; Joan Albanell
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients.
British journal of cancer 2010;102(7):1137-44.
2009: Clara Montagut; Jeff Settleman
Targeting the RAF-MEK-ERK pathway in cancer therapy.
Cancer letters 2009;283(2):125-34.
2008: Clara Montagut; Sreenath V Sharma; Toshi Shioda; Ultan McDermott; Matthew Ulman; Lindsey Ulkus; Dora Dias-Santagata; Hannah Stubbs; Diana Y Lee; Anurag Singh; Lisa Drew; Daniel A Haber; Jeffrey Settleman
Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma.
Cancer research 2008;68(12):4853-61.
2008: Joan Albanell; Clara Montagut; Eileen T Jones; Linda Pronk; Begoña Mellado; Janette Beech; Pere Gascon; Gerhard Zugmaier; Michael Brewster; Mark P Saunders; Juan W Valle
A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2726-31.
2007: Ultan McDermott; Sreenath V Sharma; Lori Dowell; Patricia Greninger; Clara Montagut; Jennifer Lamb; Heidi Archibald; Raul Raudales; Angela Tam; Diana Lee; S Michael Rothenberg; Jeffrey G Supko; Raffaella Sordella; Lindsey Ulkus; A John Iafrate; Shyamala Maheswaran; Ching-Ni Njauw; Hensin Tsao; Lisa Drew; Jeff H Hanke; Xiao-Jun Ma; Mark G Erlander; Nathanael S Gray; Daniel A Haber; Jeffrey Settleman
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(50):19936-41.
2007: Joaquim Bellmunt; Clara Montagut; Santiago Albiol; Joan Carles; Pablo Maroto; Anna Orsola
Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents.
BJU international 2007;99(2):274-80.
2006: Josep Domingo-Domenech; Cristina Oliva; Ana Rovira; Jordi Codony-Servat; MARTA BOSCH; Xavier Filella; Clara Montagut; Maria Angeles Tapia; Clara Campás; Lenny Dang; Mark Rolfe; Jeffrey S Ross; Pere Gascon; Joan Albanell; Begoña Mellado
Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5578-86.
2006: Clara Montagut; Ignasi Tusquets; Berta Ferrer; Josep M Corominas; Beatriz Bellosillo; C Campas; Marta Suarez; Xavier Fabregat; Elias Campo; Pere Gascon; Sergi Serrano; Pedro L Fernandez; Ana Rovira; Joan Albanell
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Endocrine-related cancer 2006;13(2):607-16.
2006: Clara Montagut; Ana Rovira; Joan Albanell
The proteasome: a novel target for anticancer therapy.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2006;8(5):313-7.
2005: Clara Montagut; Juan J Grau; Ramon Grimalt; Jordi Codony; Juan Ferrando; Joan Albanell
Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5273-5.
2005: Clara Montagut; Ana Rovira; Begoña Mellado; Pere Gascon; Jeffrey S Ross; Joan Albanell
Preclinical and clinical development of the proteasome inhibitor bortezomib in cancer treatment.
Drugs of today (Barcelona, Spain : 1998) 2005;41(5):299-315.
2005: Josep Domingo-Domènech; Rafael Molina; Teresa Castel; Clara Montagut; Susana Puig; Carlos Conill; Rosa Martí; M Vera; Jose M Auge; Josep Malvehy; Juan J Grau; Pere Gascon; Begoña Mellado
Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCR.
Oncology 2005;68(4-6):341-9.
2004: Clara Montagut; Francesc Bosch; Luis Villela; Laura Rosiñol; Joan Bladé
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide.
Leukemia & lymphoma 2004;45(8):1711-2.
2004: Mónica Santos; Clara Montagut; Begoña Mellado; Angel García; Santiago Ramón y Cajal; Antonio Cardesa; Luis M Puig-Tintoré; Jaume Ordi
Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(3):206-14.
2003: Clara Montagut; Maribel Mármol; Victoria Rey; Jaume Ordi; Jaume Pahissa; Angeles Rovirosa; Pere Gascón; Begoña Mellado
Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus.
Gynecologic oncology 2003;90(2):458-61.
2002: Begoña Mellado; Maria Del Carmen Vela; Dolors Colomer; Lorena Gutierrez; Teresa Castel; Llorenç Quintó; Montserrat Fontanillas; Noemi Reguart; Josep Domingo-Domènech; Clara Montagut; Jordi Estapé; Pere Gascón
Tyrosinase mRNA in blood of patients with melanoma treated with adjuvant interferon.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):4032-9.